glp 1 information GLP-1 The GLP-1 Knowledge Gap |
Description
Results Twenty-eight RCTs were ultimately included for analysis, involving a total of 77,485 participants
Results The study consisted of 150 patients, with 73 GLP-1 RA users in the experimental group and 77 non-users in the control group
Despite the potential clinical benefits of GLP-1RA plus SGLT2i combination therapy in patients with T2DM, several factors may delay this combination to become a common practice soon, such as reimbursement and costs associated with polypharmacy
Evidence-based guidance on protein, supplements, meal planning, and long-term weight maintenance strategies.
Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality
